Sara Nuñez Garcia

Title: Sara Nuñez Garcia: Innovator in Pharmaceutical Chemistry

Introduction

Sara Nuñez Garcia is a prominent inventor based in Weesp, Netherlands. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. Her work focuses on innovative solutions to complex medical challenges.

Latest Patents

Sara holds a patent for "Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers." This invention concerns spiro azepane-oxazolidinones as voltage-gated Kv1.3 potassium channel blockers. The patent includes pharmaceutical compositions containing these compounds, methods for preparing the compounds, and methods for preparing novel intermediates useful for their synthesis. Additionally, it outlines the uses of such compounds and compositions, particularly in treating diabetes, psoriasis, obesity, transplant rejection, and inflammatory neuropathies, including T-cell mediated autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. She has 1 patent to her name.

Career Highlights

Sara is currently employed at Abbott Healthcare Products B.V., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Sara collaborates with notable colleagues, including Pieter Smid and Michael Mlinaric, who contribute to her innovative projects and research initiatives.

Conclusion

Sara Nuñez Garcia exemplifies the spirit of innovation in pharmaceutical chemistry through her groundbreaking work and patent contributions. Her dedication to improving patient outcomes through scientific advancements is commendable.